CA1116088A - Injectable embolization and occlusion solution - Google Patents

Injectable embolization and occlusion solution

Info

Publication number
CA1116088A
CA1116088A CA320,450A CA320450A CA1116088A CA 1116088 A CA1116088 A CA 1116088A CA 320450 A CA320450 A CA 320450A CA 1116088 A CA1116088 A CA 1116088A
Authority
CA
Canada
Prior art keywords
solution
prolamine
zein
ethanol
occlusion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA320,450A
Other languages
English (en)
French (fr)
Inventor
Hans Muxfeldt
Hermann Dahlke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethicon Inc
Original Assignee
Ethicon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethicon Inc filed Critical Ethicon Inc
Application granted granted Critical
Publication of CA1116088A publication Critical patent/CA1116088A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0452—Solutions, e.g. for injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA320,450A 1978-01-30 1979-01-29 Injectable embolization and occlusion solution Expired CA1116088A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2803869A DE2803869C2 (de) 1978-01-30 1978-01-30 Injizierbare Embolisations- und Okklusionslösung
DEP2803869.9 1978-01-30

Publications (1)

Publication Number Publication Date
CA1116088A true CA1116088A (en) 1982-01-12

Family

ID=6030689

Family Applications (1)

Application Number Title Priority Date Filing Date
CA320,450A Expired CA1116088A (en) 1978-01-30 1979-01-29 Injectable embolization and occlusion solution

Country Status (8)

Country Link
JP (1) JPS54123281A (sl)
AT (1) AT363599B (sl)
AU (1) AU525929B2 (sl)
CA (1) CA1116088A (sl)
DE (1) DE2803869C2 (sl)
FR (1) FR2415464A1 (sl)
GB (1) GB2014043B (sl)
NL (1) NL191433C (sl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3374659D1 (en) * 1983-02-03 1988-01-07 Ethicon Inc Paste for hemostasis and for temporary relief of defects in the traumatism of bones
EP0128578A1 (de) * 1983-06-14 1984-12-19 Byk Gulden Lomberg Chemische Fabrik GmbH Ethanolische Kontrastmittelsuspensionen
CA1225585A (en) * 1983-06-30 1987-08-18 Maria T. Litvinova Composition for embolization of blood vessels
US4680171A (en) * 1985-03-15 1987-07-14 William Shell Visualization of a bloodstream circulation with biodegradable microspheres
DE19608278A1 (de) * 1996-02-23 1997-08-28 Schering Ag Pharmazeutische Mittel enthaltend perfluoralkylhaltige Metallkomplexe, und ihre Verwendung in der Tumortherapie und interventioniellen Radiologie
US6180113B1 (en) 1996-02-23 2001-01-30 Schering Ag Pharmaceutical agents that contain perfluoroalkyl-containing metal complexes
KR970069028A (ko) * 1996-04-01 1997-11-07 김은영 화학색전용 에멀젼의 제조방법
US6333020B1 (en) * 1999-05-13 2001-12-25 Micro Therapeutics, Inc. Methods for treating AVM's using radio active compositions
DE10261694A1 (de) * 2002-12-30 2004-07-15 Brassel, Friedhelm, Prof. Dr.med. Flüssiges Embolisat
ES2640456T3 (es) 2006-09-18 2017-11-03 Fumedica Ag Agente de contraste de rayos X para la angiografía post mortem, experimental y diagnóstica
CH712511B1 (de) * 2006-09-18 2017-11-30 Forim-X Ag C/O Prof Dr Med Richard Dirnhofer Röntgenkontrastmittel für die postmortale, experimentelle und diagnostische Angiographie.
CN107935870A (zh) * 2017-11-09 2018-04-20 华中药业股份有限公司 一种2‑甲氨基‑5‑氯二苯甲酮的合成方法
CN113813392A (zh) * 2021-10-23 2021-12-21 哈尔滨工业大学 一种仿血细胞药物载体的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB311382A (en) * 1928-05-10 1930-08-07 H A Metz Lab Inc Improvements in or relating to the manufacture of spinal anaesthetic solutions
CA958642A (en) * 1969-06-11 1974-12-03 Milos Sovak Contrast media for radiography

Also Published As

Publication number Publication date
NL191433B (nl) 1995-03-01
NL7900649A (nl) 1979-08-01
ATA65679A (de) 1981-01-15
AU525929B2 (en) 1982-12-09
NL191433C (nl) 1995-07-04
JPS54123281A (en) 1979-09-25
DE2803869C2 (de) 1983-12-29
AT363599B (de) 1981-08-10
FR2415464B1 (sl) 1983-07-01
AU4343079A (en) 1979-08-09
JPH0129774B2 (sl) 1989-06-14
FR2415464A1 (fr) 1979-08-24
DE2803869A1 (de) 1979-08-02
GB2014043B (en) 1982-08-11
GB2014043A (en) 1979-08-22

Similar Documents

Publication Publication Date Title
US4268495A (en) Injectable embolization and occlusion solution
Yakes et al. Serial embolizations of an extremity arteriovenous malformation with alcohol via direct percutaneous puncture
EP1154723B1 (en) Cyanoacrylates comprising inhibitors and an opacifying agent
CA1116088A (en) Injectable embolization and occlusion solution
US5614204A (en) Angiographic vascular occlusion agents and a method for hemostatic occlusion
JP3804071B2 (ja) 部分的に加水分解されたポリビニルアセテートを含有する液体塞栓剤
Samson et al. Intravascular use of isobutyl 2-cyanoacrylate: part 1: treatment of intracranial arteriovenous malformations
US20030223955A1 (en) Methods for embolizing aneurysmal sites with a high viscosity embolizing composition
US4847065A (en) Composition for occlusion of ducts and cavities of human body
Hamada et al. A nonadhesive liquid embolic agent composed of ethylene vinyl alcohol copolymer and ethanol mixture for the treatment of cerebral arteriovenous malformations: experimental study
Hamada et al. A mixture of ethylene vinyl alcohol copolymer and ethanol yielding a nonadhesive liquid embolic agent to treat cerebral arteriovenous malformations: initial clinical experience
Matsumaru et al. Embolic materials for endovascular treatment of cerebral lesions
Muto et al. Therapeutic embolization of oral hemangiomas with absolute ethanol
Kumar et al. Preoperative embolization of hypervascular head and neck neoplasms using microfibrillar collagen.
WO2020221283A1 (zh) 一种乙醇类硬化剂及其应用
Slaba et al. Therapeutic approach to arteriovenous malformations of the tongue
RU2394574C1 (ru) Способ коррекции ишемического поражения печени
Niechajev et al. Histologic investigation of vascular malformations of the face after transarterial embolization with ethibloc and other agents
CA2602281C (en) Gynecological drugs encapsulated in sodium alginate microspheres for use in embolotherapy
Rossi et al. Facial artery arteriovenous malformation endovascular and surgical treatment: liquid embolic device an advantage for both technique
Silber Renal trauma: Treatment by angiographic injection of autologous clot
Sandro Rossitti Transarterial embolization of intracranial dural arteriovenous fistulas with direct cortical venous drainage using ethylene vinyl alcohol copolymer (Onyx)
Chang et al. Use of percutaneous foam sclerotherapy with 1.5% sodium tetradecyl sulfate for treatment of a pelvic limb venous malformation in a dog
Shi et al. Experimental study of Eudragit mixture as a new nonadhesive liquid embolic material
Kamphorst et al. New technique for superselective arterial (chemo-) embolization of the rat liver

Legal Events

Date Code Title Description
MKEX Expiry